Centre for Blood Transplant and Cell Therapy

Congratulations to the recipients of the SWTCRC ECR Accelerator Grant. Dr Ali Azimi, Dr Caroline Bateman & Dr David Bishop. 🎉👏 @WestmeadInst @cancerNSW @CTSR_USyd @CBTCT

Want to stay up to date on #GvHD but not able to follow #EBMT20Virtual? Then look no further, as the @gvhd_hub will be covering the meeting this week and disseminating all the latest information on GvHD! #bmtsm #gvhdsm

📢Join the NHMRC @CBTCT next webinar on #GvHD on Thurs 20 Aug 8am (AEST / 10am NZST) via Zoom uni-sydney.zoom.us/j/94221892850 All welcome to attend!

@abmtrr_stats Recordings or links to the webinars will be available soon on the CBTCT website: bloodcelltherapy.org.au

Join the NHMRC @CBTCT Centre for Blood Transplant and Cell Therapy for its first Webinar - Join via ZOOM uni-sydney.zoom.us/j/94221892850

Hope and progress towards a world without blood #cancer ❤️

Have you read the latest #hematology academic research in our Leukemia journal?

The newest issue of Blood Advances is now available ow.ly/C0xJ50AybCp #hematology

Beating cancer is in our blood. #FightBloodCancer ❤️

ctDNA helpful in detecting potentially targetable mutations in lymphoma @MilesPrince4 @PeterMacCC @SnowdomeAU thelimbic.com/haematology/li…

While we hope an in-person #ASH20 may still be possible, we understand that many already know they are not able to travel in December. Therefore, we are pleased to announce that there will be a virtual option, whether we have an in-person component or not.

CRISPR-based screens uncover determinants of #immunotherapy response in multiple myeloma ow.ly/XRmT50ArToc #mmsm

BREAKING NEWS: @US_FDA approved a new therapy for myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) that can be taken at home, reducing the need for frequent visits to health care facilities. Learn more >> bit.ly/2O3rUur

RT @gjmccaughan: I have been so fortunate to be supported by the Zamasa Foundation in undertaking a Fellowship in Multiple Myeloma at @SVHS…

Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation ow.ly/ck9n50AftHc

RT @ThomasKupper3: Host T cells are a major driver of inflammation in GVHD, a challenge to the prevailing paradigm twitter.com/brighamresearc…

Congratulations to @StevenLane_QIMR, @ALLGtrials member and clinician-scientist from @QIMRBerghofer for his new publication in @NatureComms on how early genetic changes in blood and bone marrow cells can lead to the development of blood cancer.

WIMR's researchers are pioneering personalised prevention strategies, treatments and cures to solve some of the greatest disease challenges of our time. Looking to start your career in medical research? Check out our current student opportunities: bit.ly/2NMD6L5

RT @MyelomaAmarc: CAR T-cell therapy could ‘revolutionize’ treatment of advanced multiple myeloma $JNJ #JNJ4528 ow.ly/YvNA50zW73k